ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur Respir J 1996; 9:402-405
Copyright ©ERS Journals Ltd 1996

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maziak, D.
Right arrow Articles by Maurer, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maziak, D.
Right arrow Articles by Maurer, J

Original Articles

Extrathoracic angiomyolipomas in lymphangioleiomyomatosis

DE Maziak, S Kesten, DC Rappaport, and J Maurer

Pulmonary lymphangioleiomyomatosis (LAM) is a rare disorder that affects women and can lead to serious respiratory impairment. Since Bourneville's tuberous sclerosis (TS) was first reported, the striking similarities between the two entities have led many to believe that LAM is a forme fruste of TS. This is suggested by reports that angiomyolipomas, rare tumours in themselves, are reported in 40-80% of TS patients and occur in 15-30% of LAM patients. A retrospective chart review was conducted of 14 patients that presented to our institution with a diagnosis of LAM. We sought to document the clinical manifestations, particularly the incidence and location of extrathoracic tumours, in order to further support the hypothesis that LAM is a forme fruste of TS. Twelve patients had premenopausal onset of symptoms and two postmenopausal. The diagnosis was confirmed histologically (n = 12) and/or by computed tomography (CT) scan of the thorax (n = 12). Imaging investigations revealed extrathoracic tumours in 12 of 14 patients (86%). Eight of the 14 patients (57%) had renal tumours consistent with angiomyolipomas (bilateral in five patients). Only one patient had renal symptoms (flank pain and haematuria). All had normal serum creatinine, one had a reduced creatinine clearance. Extrathoracic nonrenal tumours were discovered in the pancreas, adrenals and uterus, findings previously unreported in LAM. In summary, the incidence of extrathoracic tumours in lymphangioleiomyomatosis patients is much higher than previously reported in the literature. This increased association supports the theory that lymphangioleiomyomatosis and tuberous sclerosis represent part of a spectrum of a similar disease process.


This article has been cited by other articles:


Home page
RadiologyHome page
A. K. Attili and E. A. Kazerooni
Case 116: Lymphangioleiomyomatosis
Radiology, July 1, 2007; 244(1): 303 - 308.
[Full Text] [PDF]


Home page
Eur Respir JHome page
S. R. Johnson
Lymphangioleiomyomatosis.
Eur. Respir. J., May 1, 2006; 27(5): 1056 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E. Battistini, C. Gambini, U. G. Rossi, L. Fazio, U. Catrambone, G. Pittaluga, P. Toma, and G. A. Rossi
Spontaneous pneumothorax in a 24-year-old female
Eur. Respir. J., March 1, 2005; 25(3): 575 - 580.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
X. Zhe, Y. Yang, and L. Schuger
Imbalanced Plasminogen System in Lymphangioleiomyomatosis: Potential Role of Serum Response Factor
Am. J. Respir. Cell Mol. Biol., January 1, 2005; 32(1): 28 - 34.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
X. Zhe and L. Schuger
Combined Smooth Muscle and Melanocytic Differentiation in Lymphangioleiomyomatosis
J. Histochem. Cytochem., December 1, 2004; 52(12): 1537 - 1542.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. E. Evans, T. V. Colby, J. H. Ryu, and A. H. Limper
Transforming Growth Factor-{beta}1 and Extracellular Matrix-Associated Fibronectin Expression in Pulmonary Lymphangioleiomyomatosis
Chest, March 1, 2004; 125(3): 1063 - 1070.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
X. Zhe, Y. Yang, S. Jakkaraju, and L. Schuger
Tissue Inhibitor of Metalloproteinase-3 Downregulation in Lymphangioleiomyomatosis: Potential Consequence of Abnormal Serum Response Factor Expression
Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 504 - 511.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. H. Ryu, C. H. Doerr, S. D. Fisher, E. J. Olson, and S. A. Sahn
Chylothorax in Lymphangioleiomyomatosis
Chest, February 1, 2003; 123(2): 623 - 627.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S R Johnson and A E Tattersfield
Clinical experience of lymphangioleiomyomatosis in the UK
Thorax, December 1, 2000; 55(12): 1052 - 1057.
[Abstract] [Full Text]


Home page
RadiologyHome page
N. A. Avila, J. A. Kelly, S. C. Chu, A. J. Dwyer, and J. Moss
Lymphangioleiomyomatosis: Abdominopelvic CT and US Findings
Radiology, July 1, 2000; 216(1): 147 - 153.
[Abstract] [Full Text]


Home page
ChestHome page
H. Logginidou, X. Ao, I. Russo, and E. P. Henske
Frequent Estrogen and Progesterone Receptor Immunoreactivity in Renal Angiomyolipomas From Women With Pulmonary Lymphangioleiomyomatosis*
Chest, January 1, 2000; 117(1): 25 - 30.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. C. Chu, K. Horiba, J. Usuki, N. A. Avila, C. C. Chen, W. D. Travis, V. J. Ferrans, and J. Moss
Comprehensive Evaluation of 35 Patients With Lymphangioleiomyomatosis
Chest, April 1, 1999; 115(4): 1041 - 1052.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S. Johnson
Rare diseases bullet  1: Lymphangioleiomyomatosis: clinical features, management and basic mechanisms
Thorax, March 1, 1999; 54(3): 254 - 264.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the European Respiratory Society.